CVE-2026-50044 Pronetiqs CVE debrief

Who should care

Security teams responsible for Pronetiqs IntraVUE versions 3.2.1a14 and prior should assess and mitigate the inadequate encryption strength vulnerability. This includes teams responsible for vulnerability management, incident response, and security operations.

Technical summary

Pronetiqs IntraVUE versions 3.2.1a14 and prior have an inadequate encryption strength vulnerability. This weakness could allow an attacker to steal admin credentials via weak hash or a pass-the-hash attack. The vulnerability has a CVSS score of 7.6 and a severity of HIGH. The affected product is Pronetiqs IntraVUE, and the vulnerability is related to inadequate encryption strength.

Defensive priority

High priority should be given to updating or patching Pronetiqs IntraVUE versions 3.2.1a14 and prior to address the inadequate encryption strength vulnerability.

Recommended defensive actions

• Inventory and assess Pronetiqs IntraVUE versions 3.2.1a14 and prior for vulnerability exposure
• Implement compensating controls to mitigate the risk of weak hash or pass-the-hash attacks
• Monitor for potential exploitation attempts
• Update or patch Pronetiqs IntraVUE to a version that addresses the inadequate encryption strength vulnerability
• Review compensating controls for exposed systems while remediation is scheduled and verified

Evidence notes

The CVE record and NVD detail provide information on the vulnerability, but additional evidence is limited. Further investigation and verification are necessary to fully understand the scope and impact of the vulnerability. The source item URL and CISA reference provide some context, but more information is needed to assess the vulnerability's impact.

Official resources